Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
Background: Metformin, a commonly used antidiabetic medication, is available in both an immediate-release (IR) formulation and a long-acting formulation (metformin extended-release; XR).Objective: We performed a systematic review to compare the effectiveness, safety, and patient compliance and satis...
Main Authors: | Jixue Tan, Yang Wang, Song Liu, Qingyang Shi, Xu Zhou, Yiling Zhou, Xiaoling Yang, Pingshan Chen, Sheyu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.669814/full |
Similar Items
-
Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey
by: Chang Liu, et al.
Published: (2021-07-01) -
Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes
by: Derosa G, et al.
Published: (2017-05-01) -
METFORMIN: FROM IMMEDIATE RELEASE TO EXTENDED RELEASE FORMULA, EFFECTIVENESS, AND SAFETY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: Giuseppe Derosa, et al.
Published: (2020-11-01) -
Efficacy and Safety of Ivabradine Once-Daily Prolonged-Release versus Twice-Daily Immediate-Release Formulation in Patients with Stable Chronic Heart Failure with Systolic Dysfunction: A Randomized, Double-Blind, Phase 3 Non-Inferiority (PROFICIENT) Study
by: Ajit Mullasari, et al.
Published: (2020-10-01) -
Metformin Enhances Excitatory Synaptic Transmission onto Hippocampal CA1 Pyramidal Neurons
by: Wen-Bing Chen, et al.
Published: (2020-10-01)